Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.05 par value
-
Shares outstanding
-
2K
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
12M
-
Shares change
-
-58.6K
-
Total reported value, excl. options
-
$474M
-
Value change
-
-$2.1M
-
Put/Call ratio
-
0.42
-
Number of buys
-
64
-
Number of sells
-
-50
-
Price
-
$39.60
Significant Holders of SURMODICS INC - Common Stock, $0.05 par value (SRDX) as of Q4 2024
154 filings reported holding SRDX - SURMODICS INC - Common Stock, $0.05 par value as of Q4 2024.
SURMODICS INC - Common Stock, $0.05 par value (SRDX) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12M shares
.
Largest 10 shareholders include BlackRock, Inc. (1.15M shares), ALLIANCEBERNSTEIN L.P. (1.01M shares), VANGUARD GROUP INC (803K shares), MORGAN STANLEY (675K shares), Qube Research & Technologies Ltd (454K shares), Soleus Capital Management, L.P. (394K shares), DIMENSIONAL FUND ADVISORS LP (380K shares), STATE STREET CORP (374K shares), Trigran Investments, Inc. (368K shares), and GABELLI FUNDS LLC (340K shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.